Evidence map›Paper›PMID 17061307›Full record

ArticleAngewandte Chemie (International ed. in English)2006

On the acceptor substrate of C-glycosyltransferase UrdGT2: three prejadomycin C-Glycosides from an engineered mutant of Streptomyces globisporus 1912 DeltalndE(urdGT2).

Irfan Baig, Madan Kharel, Anton Kobylyanskyy, Lili Zhu, Yuriy Rebets, Bohdan Ostash, Andriy Luzhetskyy, Andreas Bechthold, Victor A Fedorenko, Jürgen Rohr

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. OleD Loki as a Catalyst for Hydroxamate Glycosylation.Chembiochem : a European journal of chemical biology · 2020
    Article
  3. Review
  4. Article
  5. OleD Loki as a Catalyst for Tertiary Amine and Hydroxamate Glycosylation.Chembiochem : a European journal of chemical biology · 2017
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Irfan BaigUniversity of Kentucky, Department of Pharmaceutical Sciences, College of Pharmacy, 725 Rose Street, Lexington, KY 40536-0082, USA.
Madan Kharel
Anton Kobylyanskyy
Lili Zhu
Yuriy Rebets
Bohdan Ostash
Andriy Luzhetskyy
Andreas Bechthold
Victor A Fedorenko
Jürgen Rohr

Funding

BIOSYNTHETIC KEY STEPS OF ANGUCYCLINE ANTITUMOR DRUGSR01CA102102 · NCI · UNIVERSITY OF KENTUCKY · PI ROHR, JURGEN T · 2005 to 2009
$1.3M
NCI NIH HHS CA 102102NCI NIH HHS R01 CA102102
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic EngineeringAminoglycosidesGlycosidesGlycosyltransferasesIsoquinolinesModels, ChemicalMolecular StructureMutationNaphthoquinonesStreptomycesAminoglycosidesGlycosidesGlycosyltransferasesIsoquinolineslandomycin ENaphthoquinonesprejadomycin

Identifiers

PMID17061307
PMCPMC2881212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.